Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus.
Morand EF, Pike M, Merrill J, F van Vollenhoven R, Werth VP, Hobar C, Delev N, Shah V, Sharkey B, Wegman T, Catlett I, Banerjee S, Singhal S.
Morand EF, et al. Among authors: banerjee s.
Expert Opin Investig Drugs. 2024 May 29:1-11. doi: 10.1080/13543784.2024.2337736. Online ahead of print.
Expert Opin Investig Drugs. 2024.
PMID: 38807572